Page last updated: 2024-12-06

prothiophos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

prothiophos: caused hypoglycemia & reduced blood urea levels in rats; structure in first source; inhibits acetylcholinesterase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

prothiofos : An organic thiophosphate that is the 2,4-dichlorophenyl ester of O-ethyl S-propyl dithiophosphoric acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID36870
CHEMBL ID1560680
CHEBI ID38873
SCHEMBL ID26428
MeSH IDM0100312

Synonyms (52)

Synonym
phosphorodithioic acid, o-(2,4-dichlorophenyl) o-ethyl s-propyl ester
tokuthion
toyodan
o-(2,4-dichlorophenyl) o-ethyl s-propylphosphorodithioate
o-(2,4-dichlorophenyl) o-ethyl s-propyl phosphorodithioate
bay ntn 8629
ntn-8629
toyothion
brn 1998314
caswell no. 714h
prothiofos [bsi:iso]
ntn 8629,4541
einecs 252-125-7
ai3-29305
epa pesticide chemical code 128858
o-ethyl-o-(2,4-dichlorophenyl)-s-n-propyl-dithiophosphate
bay-ntn 8629
bideron
tokuthion, technical grade, pkg of 50 mg
NCGC00166172-01
o-(2,4-dichlorophenyl) o-ethyl s-propyl dithiophosphate
34643-46-4
prothiophos
o-(2,4-dichlorophenyl) o-ethyl s-propyl phosphorodithionate
CHEBI:38873 ,
dichlorpropaphos
prothiofos
AC-12074
C18405
cas-34643-46-4
NCGC00255952-01
dtxsid8042349 ,
tox21_301219
dtxcid6022349
AKOS015960703
h5232196gp ,
unii-h5232196gp
SCHEMBL26428
CHEMBL1560680
prothiofos [iso]
(rs)-(o-2,4-dichlorophenyl o-ethyl s-propyl phosphorodithioate)
prothiofos, (+/-)-
prothiofos [jan]
(+/-)-prothiofos
o-(2,4-dichlorophenyl) o-ethyl s-propyl dithiophosphate #
prothiofos, pestanal(r), analytical standard
prothiophos 10 microg/ml in acetonitrile
prothiophos 10 microg/ml in cyclohexane
J-019687
(2,4-dichlorophenoxy)-ethoxy-propylsulfanyl-sulfanylidene-lambda5-phosphane
Q22808805
prothiophos 100 microg/ml in acetonitrile
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
EC 3.1.1.8 (cholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
organic thiophosphate
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
organosulfur compoundAn organosulfur compound is a compound containing at least one carbon-sulfur bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency12.55940.140911.194039.8107AID2451
phosphopantetheinyl transferaseBacillus subtilisPotency50.11870.141337.9142100.0000AID1490
AR proteinHomo sapiens (human)Potency27.02910.000221.22318,912.5098AID1259243; AID1259247
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency54.48270.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency23.56190.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency13.68540.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency34.66540.000817.505159.3239AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency30.63790.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency46.76260.000229.305416,493.5996AID743075; AID743079
aryl hydrocarbon receptorHomo sapiens (human)Potency43.46800.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.24340.001628.015177.1139AID1259385
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency34.16320.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency126.79300.039147.5451146.8240AID1224845
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency7.07950.354828.065989.1251AID504847
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065; AID743067
DNA polymerase kappa isoform 1Homo sapiens (human)Potency23.77810.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (16.67)18.7374
1990's2 (11.11)18.2507
2000's9 (50.00)29.6817
2010's2 (11.11)24.3611
2020's2 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.03 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (19.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies2 (10.53%)4.05%
Observational0 (0.00%)0.25%
Other16 (84.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]